ValuEngine upgraded shares of Sabra Health Care REIT (NASDAQ:SBRA) from a strong sell rating to a sell rating in a research report report published on Thursday morning.

Other equities analysts also recently issued reports about the company. Jefferies Financial Group reiterated a $21.91 rating and issued a $22.00 price target on shares of Sabra Health Care REIT in a research note on Wednesday, July 18th. TheStreet upgraded Sabra Health Care REIT from a c+ rating to a b- rating in a research note on Wednesday, June 6th. BidaskClub downgraded Sabra Health Care REIT from a strong-buy rating to a buy rating in a research note on Wednesday, July 18th. Zacks Investment Research upgraded Sabra Health Care REIT from a hold rating to a buy rating and set a $25.00 price target for the company in a research note on Wednesday, July 11th. Finally, Cantor Fitzgerald reiterated a buy rating and issued a $25.00 price target on shares of Sabra Health Care REIT in a research note on Monday, June 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. Sabra Health Care REIT currently has an average rating of Hold and an average target price of $22.40.

Shares of Sabra Health Care REIT traded down $0.21, hitting $22.08, during trading hours on Thursday, Marketbeat reports. 714,576 shares of the company’s stock traded hands, compared to its average volume of 1,191,771. The company has a debt-to-equity ratio of 1.00, a current ratio of 3.16 and a quick ratio of 1.55. The company has a market capitalization of $3.97 billion, a PE ratio of 9.09, a P/E/G ratio of 2.69 and a beta of 0.70. Sabra Health Care REIT has a twelve month low of $15.77 and a twelve month high of $23.79.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, August 8th. The real estate investment trust reported $1.08 EPS for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.75. The business had revenue of $166.31 million during the quarter, compared to the consensus estimate of $166.62 million. Sabra Health Care REIT had a return on equity of 11.21% and a net margin of 62.60%. equities analysts expect that Sabra Health Care REIT will post 2.51 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 31st. Shareholders of record on Saturday, August 18th will be issued a $0.45 dividend. The ex-dividend date is Thursday, August 16th. This represents a $1.80 dividend on an annualized basis and a yield of 8.15%. Sabra Health Care REIT’s dividend payout ratio is currently 74.07%.

Hedge funds and other institutional investors have recently modified their holdings of the business. US Bancorp DE lifted its holdings in Sabra Health Care REIT by 91.5% in the second quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock worth $124,000 after acquiring an additional 2,723 shares during the last quarter. Goodwin Daniel L bought a new position in Sabra Health Care REIT in the second quarter worth about $207,000. Oxbow Advisors LLC bought a new position in Sabra Health Care REIT in the second quarter worth about $216,000. Oppenheimer Asset Management Inc. bought a new position in Sabra Health Care REIT in the first quarter worth about $236,000. Finally, Atria Investments LLC lifted its holdings in Sabra Health Care REIT by 34.3% in the first quarter. Atria Investments LLC now owns 14,908 shares of the real estate investment trust’s stock worth $263,000 after acquiring an additional 3,807 shares during the last quarter. 87.35% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

As of March 31, 2018, Sabra's investment portfolio included 515 real estate properties held for investment (consisting of (i) 380 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), five assets held for sale, one investment in a direct financing lease, 21 investments in loans receivable (consisting of (i) two mortgage loans, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 15 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Read More: Short Selling Stocks and Day Traders

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.